Hot sale Cetrorelix - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

To be able to give you benefit and enlarge our business, we also have inspectors in QC Team and assure you our greatest service and products for 157810-81-6, L-(+)-Arginine, Sofosbuvir, We warmly welcome clients from all around the world for almost any sort of cooperation with us to build a mutual advantage potential. We've been devoting ourselves wholeheartedly to supply consumers the very best company.
Hot sale Cetrorelix - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity – Ruifu Detail:

Manufacturer Supply with High Purity and Stable Quality
Chemical Name: Lasofoxifene Tartrate 
CAS: 190791-29-8
Appearance: White to Off-White Powder
Chiral Purity: ≥99.0%   Purity: ≥98.0% (HPLC)
Lasofoxifene Tartrate (CAS: 190791-29-8) in the treatment of Postmenopausal Osteoporosis

Chemical Name Lasofoxifene Tartrate
Synonyms (5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol Tartrate Oporia
CAS Number 190791-29-8
CAT Number RF-API20
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C28H31NO2.ClH
Molecular Weight 450.019
Brand Ruifu Chemical
Item Specifications
Appearance White to Off-White Powder 
Moisture (K.F) ≤0.50%
Heavy Metals ≤20ppm
Chiral Purity ≥99.0%
Purity / Analysis Method ≥98.0% (HPLC)
Loss on Drying ≤0.50%
Residue on Ignition ≤0.50%
Test Standard Chinese Pharmacopoeia (CP); Enterprise Standard
Usage Active Pharmaceutical Ingredient (API); Postmenopausal Osteoporosis

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1
2

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Lasofoxifene Tartrate (CAS: 190791-29-8) with high quality.
Lasofoxifene Tartrate is a third-generation, non-steroidal selective estrogen receptor modulator (SERM). It selectively binds to human ERalpha with an IC50 value of 1.5 nM and inhibits bone loss in ovariectomized rats. In clinical studies of postmenopausal osteoporosis, 0.5 mg/day lasofoxifene was associated with reduced risks of nonvertebral and vertebral fractures, ER-positive breast cancer, coronary heart disease, and stroke but an increased risk of venous thromboembolic events. Lasofoxifene has also been shown to act as an inverse agonist at the CB2 cannabinoid receptor, indicating its potential to be repurposed as a therapeutic for indications wherein CB2 is a target. 


Product detail pictures:

Hot sale Cetrorelix - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity  – Ruifu detail pictures


Related Product Guide:

We always continually offer you by far the most conscientious customer service, and the widest variety of designs and styles with finest materials. These attempts include the availability of customized designs with speed and dispatch for Hot sale Cetrorelix - Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API High Purity – Ruifu , The product will supply to all over the world, such as: Bulgaria, California, Iran, As an experienced manufacturer we also accept customized order and we could make it the same as your picture or sample specification. The main goal of our company is to live a satisfactory memory to all the customers, and establish a long term business relationship with buyers and users all over the world.
  • Timely delivery, strict implementation of the contract provisions of the goods, encountered special circumstances, but also actively cooperate, a trustworthy company!
    5 Stars By Irma from Sydney - 2018.11.04 10:32
    This supplier offers high quality but low price products, it is really a nice manufacturer and business partner.
    5 Stars By Michelle from French - 2018.09.19 18:37
    Write your message here and send it to us